Alvityl Vitamine D3 goutte
Food supplement declared in France, declaration No 2021-5-376
Alvityl Vitamine D3 goutte is a food supplement declared in France. Status: retrait du marché annoncé pour le 31 May 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRES URGO HEALTHCARE
- Status
- Retrait du marché annoncé pour le 31 May 2027
- Form
- Compte-gouttes
- Daily dose
- 1 à 3 gouttes par jour
- Directions for use
- 3 à 10 ans: 1 goutte/j. Plus de 10ans, adolescent et adulte: 3 gouttes/j
- Intended populations
- Enfants de 4 à 10 ans, Adolescents de 11 à 17 ans, Personnes de plus de 60 ans, Homme, Femme
- Objectives stated by the manufacturer (these are not authorised claims)
- Croissance et developpement, Os, Santé bucco-dentaire, Immunité
Declaration 224760, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 31 May 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
Additives
E306
Other ingredients
huile d'olive
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Les enfants supplémentés en vitamine D doivent demander conseil à leur médecin avant de prendre ce produit.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.